You are viewing the site in preview mode

Skip to main content

Advertisement

Table 3 Patient characteristics of 37 cases prior to re-irradiation

From: Population-based outcomes after whole brain radiotherapy and re-irradiation in patients with metastatic breast cancer in the trastuzumab era

Patient Characteristics prior to re-BRT n =37
Age (years)  
   Median 48
KPS  
   < 70 10 (27%)
   ≥ 70 27 (73%)
ECOG  
   0-1 12 (32%)
   2 20 (54%)
   3-4 5 (13%)
Number of lesions  
   1-3 15 (40%)
   > 3 22 (59%)
Primary status  
   Controlled 22 (59%)
   Uncontrolled 15 (40%)
Extracranial disease  
   Brain only 10 (27%)
   Bone 6 (16%)
   Visceral 19 (51%)
   Other 2 (5%)
RPA at re-BRT  
   1 12 (32%)
   2 10 (27%)
   3 15 (40%)
Chemotherapy at BM*  
   Yes 19 (51%)
   No 18 (49%)
Trastuzumab at BM*  
   Yes 6 (16%)
   No 31 (84%)
  1. * Refers to treatments given on or after the date of brain re-irradiation.
  2. Abbreviations: re-BRT = re-irradiation, RPA = recursive partitioning analysis, KPS = karnofsky performance status, ECOG = eastern cooperative oncology group performance status, BM = brain metastasis